×

Back

Feras Ayman Moria MBBS,FRCPC, ABIM

Assistant Professor, College of Medicine – King Abdulaziz University Consultant, Medical Oncology & Internal Medicine

Years of Experience: 9

x SURGEON
★ ★ ★ ★ ★ 5/5
En Ar

Fellowships

Fellowship

Subspecialty fellowship in Breast Oncology, Phase I clinical trials, and drug development – McGill University, Canada -2025

Fellowship

Subspecialty fellowship in Genitourinary Oncology – McGill University, Canada - 2025

Fellowship

American board certification in Medical Oncology - 2024

Membership

  • American Society of Clinical Oncology 
  • Fellow of the Royal College of Physicians (FRCPC)

License

  • Saudi Commission for Health Specialties
  • CMQ Collège des médecins du Québec 

Achievements & Career Highlights

  • Assistant Professor, College of Medicine, KAU 2025 to present
  • July 2024 – June 2025: Staff medical oncologist – Locum, Lakeshore general Hospital, Montreal, Quebec, Canada

Publications

  • Park CL, Moria FA, et al.
    Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. Current Oncology. 2024;31(8):4704–4712. doi:10.3390/curroncol31080351.

  • Castellano CA, et al. (including Feras A. Moria); COVID-19 and Cancer Consortium.
    The Impact of Cancer Metastases on COVID-19 Outcomes: A Registry-Based Retrospective Cohort Study. Cancer. 2024. doi:10.1002/cncr.35247.

  • Moria FA, Park CL, Eigl BJ, Macfarlane R, Pavic M, Saleh RR.
    A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada. Current Oncology. 2024;31:704–722. doi:10.3390/curroncol31020052.

  • Germanos K, Park CL, Saleh RR, Moria FA.
    Mycobacterium bovis Sternoclavicular Joint Septic Arthritis in a Patient on Avelumab for Metastatic Urothelial Cell Carcinoma. Journal of Cancer Science and Clinical Therapeutics. 2023;7:277–282.

  • Park CL, Moria F, Saleh RR.
    Combination of Osimertinib with Concurrent Chemotherapy and Hormonal Therapy for Synchronous NSCLC, Hormone Receptor–Positive Breast Cancer, and Triple-Negative Breast Cancer: A Case Report. Case Reports in Oncology. 2023;16(1):1080–1086. doi:10.1159/000533783.

  • Moria FA, Park CL, Saleh RR.
    Apalutamide-Induced Neutropenia: An Unusual Side Effect and Literature Review. Journal of Cancer Science and Clinical Therapeutics. 2023;7:135–140

  • Bakouny Z, et al. (including Feras A. Moria).
    Interplay of Immunosuppression and Immunotherapy Among Patients with Cancer and COVID-19. JAMA Oncology. 2023;9(1):128–134. doi:10.1001/jamaoncol.2022.5357.

  • Badawi M, Saaty R, Altayyari S, Khalil R, Moria F, Zaher G, Alnajjar S, Hindawi S.
    Improving Detection Rates of Suspected Acute Transfusion Reactions Through Active Surveillance. Iraqi Journal of Hematology. 2021;10(2):165–169.

  • Kari JA, Shalaby MA, Sofyani K, et al. (including Moria FA).
    Urinary Neutrophil Gelatinase–Associated Lipocalin (NGAL) and Serum Cystatin C for Early Diagnosis of Acute Kidney Injury in Children Admitted to the PICU. World Journal of Pediatrics. 2018;14(2):134–142. doi:10.1007/s12519-017-0110-x.

  • Al-Raddadi RM, Dashash NA, Alghamdi HA, et al. (including Feras A. Moria).
    Hepatitis C Virus Infection in Jeddah, Saudi Arabia: Seroprevalence and Knowledge. Journal of Medical Virology. 2017. doi:10.1002/jmv.24973.

  • Bahijri SM, Jambi HA, Al-Raddadi R, Ferns G, Tuomilehto J.
    The Prevalence of Diabetes and Pre-Diabetes in the Adult Population of Jeddah, Saudi Arabia: A Community-Based Survey. PLOS ONE. 2016;11(4). doi:10.1371/journal.pone.0152559.

  • Subki A, Alasmari A, Jan F, Moria F, Jan M.
    Reflex Seizures Triggered by Diaper Change in Dravet Syndrome. Canadian Journal of Neurological Sciences. 2016;43(4):585–587

Get the Right Care For You & Your Family